FDA Issues Fast Track Designation to Oral PIM1 Kinase Inhibitor for Myelofibrosis | Docwire News
The FDA previously granted Orphan Drug Designation to nuvisertib for use in myelofibrosis in May 2022.
Related Articles
Highlights In Therapy For Chronic Lymphocytic Leukemia (CLL) | Leukemia and Lymphoma Society
Join us for a free webinar covering the latest information for patients and caregivers.To register by phone, call (855) 441-3249. Topics CoveredWe invite you to learn more…
Medical News | Medical Articles
Medical News and articles you can trust from around the world. All content is written and reviewed by qualified health, medical and scientific experts.
New Era in Cell Therapy: Insights on Locabtogene Autoleucel | Blood Cancers Today
GPRC5D CAR T therapy shows >90% response in tough-to-treat myeloma. Dr. Susan Bal explores survival.
Uterine Cancer Awareness Month | Cancer Nursing Today
In honor of Uterine Cancer Awareness Month, marked annually in June, our editors are highlighting important news and information for oncology nurses and advanced practitioners.
Berries pack more fiber and antioxidants than America’s most-eaten fruits
Replacing one daily serving of commonly eaten fruits like apples or bananas with berries significantly boosts nutrient density in USDA dietary patterns. The modeling analysis…
Episode 439: What’s New in COVID Injury Syndromes?
Podcast Episode · Heart Doc VIP with Dr. Joel Kahn · 06/17/2025 · 30m
Changing the Blood Diagnostic Industry With Dena Marrinucci
Podcast Episode · Healthcare Unfiltered · 06/17/2025 · 45m
Netanyahu tells ABC he’s not ruling out taking out Iran’s Supreme Leader Ayatollah Khamenei
Israeli Prime Minister Benjamin Netanyahu spoke with ABC News’ Jonathan Karl about Israel’s attack on Iran’s nuclear program and Iran’s retaliation against his country.
Men’s Heart Health: An End to Heart Attacks: Joel Kahn, MD: Integrative Cardiologist
The matter of heart attack prevention is pressing because over 1,000 people a day in the US alone experience a heart death judged to be…
2 New Studies Show CVD Benefit of Portfolio Diet
The plant-based, cholesterol-lowering diet is associated with a reduced risk for cardiovascular disease and mortality across diverse groups.